ALTIMMUNE, INC. Stock-Based Compensation
ALTIMMUNE, INC. (ALT) reported Stock-Based Compensation of $6.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.79M, a 21.82% decline year-over-year.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.38M, a 15.87% decline year-over-year.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.94M, a 47.32% increase year-over-year.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.55M, a 15.46% increase year-over-year.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $16.08M, a 11.69% increase from fiscal 2024.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $14.39M, a 35.27% increase from fiscal 2023.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $10.64M, a 31.34% increase from fiscal 2022.
- ALTIMMUNE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $8.10M, a 46.78% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $6.17M 10-Q · filed 2026-08-12 | $11.11M derived: sum of 3 quarters · filed 2026-08-12 | $14.66M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $3.38M 10-Q · filed 2026-05-13 | $8.32M derived: sum of 2 quarters · filed 2026-05-13 | $11.87M derived: sum of 3 quarters · filed 2026-05-13 | $15.44M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $8.49M derived: sum of 2 quarters · filed 2026-03-06 | $12.06M derived: sum of 3 quarters · filed 2026-08-12 | $16.08M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.12M derived: sum of 2 quarters · filed 2026-08-12 | $11.13M 10-Q · filed 2025-11-06 | $14.49M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.58M 10-Q · filed 2026-08-12 | $10.94M derived: sum of 3 quarters · filed 2026-08-12 | $14.01M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $4.01M 10-Q · filed 2026-05-13 | $7.37M derived: sum of 2 quarters · filed 2026-05-13 | $10.45M derived: sum of 3 quarters · filed 2026-05-13 | $14.76M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $6.43M derived: sum of 2 quarters · filed 2026-03-06 | $10.74M derived: sum of 3 quarters · filed 2026-03-06 | $14.39M 10-K · filed 2026-03-06 | ||||
| 2024-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.39M derived: sum of 2 quarters · filed 2025-11-06 | $11.04M 10-Q · filed 2025-11-06 | $13.51M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $7.96M 10-Q · filed 2025-08-12 | $10.43M derived: sum of 3 quarters · filed 2025-08-12 | $13.14M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $3.65M 10-Q · filed 2025-05-13 | $6.12M derived: sum of 2 quarters · filed 2025-05-13 | $8.83M derived: sum of 3 quarters · filed 2025-05-13 | $11.62M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.18M derived: sum of 2 quarters · filed 2025-02-27 | $7.96M derived: sum of 3 quarters · filed 2025-02-27 | $10.64M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.50M derived: sum of 2 quarters · filed 2024-11-12 | $8.17M 10-Q · filed 2024-11-12 | $10.06M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.46M 10-Q · filed 2024-08-08 | $7.35M derived: sum of 3 quarters · filed 2024-08-08 | $9.48M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-09 | $4.57M derived: sum of 2 quarters · filed 2024-05-09 | $6.70M derived: sum of 3 quarters · filed 2024-05-09 | $8.74M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $4.02M derived: sum of 2 quarters · filed 2024-03-27 | $6.07M derived: sum of 3 quarters · filed 2024-03-27 | $8.10M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.18M derived: sum of 2 quarters · filed 2023-11-07 | $6.21M 10-Q · filed 2023-11-07 | $7.53M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.08M 10-Q · filed 2023-08-10 | $5.40M derived: sum of 3 quarters · filed 2023-08-10 | $6.90M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $2.03M 10-Q · filed 2023-05-11 | $3.35M derived: sum of 2 quarters · filed 2023-05-11 | $4.85M derived: sum of 3 quarters · filed 2023-05-11 | $6.33M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.82M derived: sum of 2 quarters · filed 2023-02-28 | $4.30M derived: sum of 3 quarters · filed 2023-02-28 | $5.52M 10-K · filed 2023-02-28 | $5.52M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.98M derived: sum of 2 quarters · filed 2022-11-10 | $4.20M 10-Q · filed 2022-11-10 | $4.20M 10-Q · filed 2021-11-09 | $4.91M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.70M 10-Q · filed 2022-08-11 | $2.70M 10-Q · filed 2021-08-10 | $3.41M derived: sum of 3 quarters · filed 2022-08-11 | $4.73M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $1.22M 10-Q · filed 2022-05-12 | $1.22M 10-Q · filed 2021-05-17 | $1.93M derived: sum of 2 quarters · filed 2022-05-12 | $3.25M derived: sum of 3 quarters · filed 2022-05-12 | $3.58M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $710.49K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.03M derived: sum of 2 quarters · filed 2022-03-15 | $2.36M derived: sum of 3 quarters · filed 2022-03-15 | $2.58M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.65M derived: sum of 2 quarters · filed 2021-11-09 | $1.87M 10-Q · filed 2021-11-09 | $2.14M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $330.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $545.43K 10-Q · filed 2021-08-10 | $824.40K derived: sum of 3 quarters · filed 2021-08-10 | $1.11M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $214.92K 10-Q · filed 2021-05-17 | $493.89K derived: sum of 2 quarters · filed 2021-05-17 | $781.67K derived: sum of 3 quarters · filed 2021-05-17 | $1.07M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $278.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $566.75K derived: sum of 2 quarters · filed 2021-02-25 | $856.52K derived: sum of 3 quarters · filed 2021-02-25 | $1.26M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $287.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $577.55K derived: sum of 2 quarters · filed 2020-11-09 | $985.26K 10-Q · filed 2020-11-09 | $1.05M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $289.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $697.49K 10-Q · filed 2020-08-11 | $766.31K derived: sum of 3 quarters · filed 2020-08-11 | $861.84K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $407.71K 10-Q · filed 2020-05-13 | $476.54K derived: sum of 2 quarters · filed 2020-05-13 | $572.07K derived: sum of 3 quarters · filed 2020-05-13 | $824.25K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $68.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $164.35K derived: sum of 2 quarters · filed 2020-03-27 | $416.54K derived: sum of 3 quarters · filed 2020-03-27 | $773.25K 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $95.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $347.72K derived: sum of 2 quarters · filed 2019-11-13 | $704.42K 10-Q · filed 2019-11-13 | $1.01M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $252.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $608.89K 10-Q · filed 2019-08-13 | $915.26K derived: sum of 3 quarters · filed 2019-08-13 | $1.37M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $356.71K 10-Q · filed 2019-05-14 | $663.08K derived: sum of 2 quarters · filed 2019-05-14 | $1.12M derived: sum of 3 quarters · filed 2019-05-14 | $1.46M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $306.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $759.40K derived: sum of 2 quarters · filed 2019-04-01 | $1.10M derived: sum of 3 quarters · filed 2019-04-01 | $1.44M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $453.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $792.09K derived: sum of 2 quarters · filed 2018-11-13 | $1.14M 10-Q · filed 2018-11-13 | $1.52M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $339.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $684.09K 10-Q · filed 2018-08-14 | $1.06M derived: sum of 3 quarters · filed 2018-08-14 | $1.26M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $345.04K 10-Q · filed 2018-05-15 | $66.18K 10-Q · filed 2017-05-03 | $725.62K derived: sum of 2 quarters · filed 2018-05-15 | $920.67K derived: sum of 3 quarters · filed 2018-05-15 | $1.13M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $380.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $575.64K derived: sum of 2 quarters · filed 2018-04-02 | $783.44K derived: sum of 3 quarters · filed 2018-04-02 | $965.37K 10-K · filed 2018-04-02 | $2.24M 10-K · filed 2017-03-14 | |||
| 2016-09-30 | $195.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $402.86K derived: sum of 2 quarters · filed 2017-11-09 | $584.78K 10-Q · filed 2017-11-09 | $1.90M 10-Q · filed 2016-11-04 | $770.81K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $207.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $389.73K 10-Q · filed 2017-08-14 | $348.72K 10-Q · filed 2016-08-04 | $575.76K derived: sum of 3 quarters · filed 2017-08-14 | $669.51K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $181.92K 10-Q · filed 2017-05-03 | $367.95K derived: sum of 2 quarters · filed 2017-05-03 | $461.71K derived: sum of 3 quarters · filed 2017-05-03 | $595.31K derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | $186.03K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $279.79K derived: sum of 2 quarters · filed 2017-03-14 | $413.39K derived: sum of 3 quarters · filed 2017-03-14 | $613.02K 10-K · filed 2017-03-14 | ||||
| 2015-09-30 | $93.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $227.36K derived: sum of 2 quarters · filed 2016-11-04 | $426.99K 10-Q · filed 2016-11-04 | $909.93K derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $133.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $333.23K 10-Q · filed 2016-08-04 | $816.17K derived: sum of 3 quarters · filed 2017-03-14 | $1.10M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | $199.63K 10-Q · filed 2016-05-09 | $682.57K derived: sum of 2 quarters · filed 2017-03-14 | $963.29K derived: sum of 3 quarters · filed 2017-03-14 | $1.33M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | $482.94K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $763.66K derived: sum of 2 quarters · filed 2017-03-14 | $1.13M derived: sum of 3 quarters · filed 2017-03-14 | $1.66M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $280.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $643.83K derived: sum of 2 quarters · filed 2015-11-06 | $1.17M 10-Q · filed 2015-11-06 | $1.58M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $363.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $891.98K 10-Q · filed 2015-08-05 | $1.30M derived: sum of 3 quarters · filed 2016-03-11 | $1.60M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $528.88K 10-Q · filed 2015-05-07 | $934.33K derived: sum of 2 quarters · filed 2016-03-11 | $1.24M derived: sum of 3 quarters · filed 2016-03-11 | $1.56M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $405.45K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $710.13K derived: sum of 2 quarters · filed 2016-03-11 | $1.03M derived: sum of 3 quarters · filed 2016-03-11 | $1.36M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $304.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $628.68K derived: sum of 2 quarters · filed 2014-11-06 | $957.26K 10-Q · filed 2014-11-06 | $1.35M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $324.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $652.59K 10-Q · filed 2014-08-05 | $1.05M derived: sum of 3 quarters · filed 2015-03-11 | $1.49M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $328.58K 10-Q · filed 2014-05-08 | $722.77K derived: sum of 2 quarters · filed 2015-03-11 | $1.16M derived: sum of 3 quarters · filed 2015-03-11 | $1.67M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $394.19K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $833.39K derived: sum of 2 quarters · filed 2015-03-11 | $1.35M derived: sum of 3 quarters · filed 2015-03-11 | $1.89M 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $439.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $951.25K derived: sum of 2 quarters · filed 2013-11-07 | $1.50M 10-Q · filed 2013-11-07 | $2.18M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $512.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.06M 10-Q · filed 2013-08-08 | $1.75M derived: sum of 3 quarters · filed 2014-03-11 | $2.37M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $548.66K 10-Q · filed 2013-05-08 | $1.23M derived: sum of 2 quarters · filed 2014-03-11 | $1.86M derived: sum of 3 quarters · filed 2014-03-11 | $2.40M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $684.54K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $1.31M derived: sum of 2 quarters · filed 2014-03-11 | $1.86M derived: sum of 3 quarters · filed 2014-03-11 | $2.57M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $626.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.17M derived: sum of 2 quarters · filed 2012-11-06 | $1.88M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | $544.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.26M 10-Q · filed 2012-08-07 | ||||||
| 2011-03-31 | $710.63K 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | $2.51M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |